LAMC2 Chromosome 1

Laminin subunit gamma 2
235 variants 235 Health Risk

Upload your DNA to see your personal genotypes for variants in LAMC2.

What This Gene Does
Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]
Gene Info
Gene Group
Laminin subunits
Locus Type
gene with protein product
Location
1q25.3
Ensembl
ENSG00000058085
Associated Conditions (15)
Junctional epidermolysis bullosa
LAMC2-related disorder
Junctional epidermolysis bullosa gravis of Herlitz
Epidermolysis bullosa
junctional 3A
intermediate
junctional 3B
severe
Inborn genetic diseases
Amelogenesis imperfecta type 1
non-Herlitz type
Thyroid cancer
nonmedullary
1
Abnormality of the skin
Key Variants
RS138266625
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS138728557
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
Health Risk
RS139718245
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS140649374
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS140949383
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder
Health Risk
RS141806165
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Inborn genetic diseases
Health Risk
RS141812464
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder
Health Risk
RS141901570
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
Health Risk
RS142335339
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Amelogenesis imperfecta type 1, LAMC2-related disorder
Health Risk
RS143817389
Conflicting classifications of pathogenicity
LAMC2-related disorder, Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa
Health Risk
RS145811533
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
Health Risk
RS146325169
Conflicting classifications of pathogenicity
Junctional epidermolysis bullosa, non-Herlitz type, Junctional epidermolysis bullosa
Health Risk
All Variants (235)
RSID Category Clinical Significance Conditions
RS138266625 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
RS138728557 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS139718245 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
RS140649374 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
RS140949383 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder
RS141806165 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Inborn genetic diseases
RS141812464 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, LAMC2-related disorder
RS141901570 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
RS142335339 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Amelogenesis imperfecta type 1, LAMC2-related disorder
RS143817389 Health Risk Conflicting classifications of pathogenicity LAMC2-related disorder, Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa
RS145811533 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS146325169 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, non-Herlitz type, Junctional epidermolysis bullosa
RS147657304 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
RS147889360 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS148065050 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS148925665 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, LAMC2-related disorder, Junctional epidermolysis bullosa
RS149718832 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS1660064320 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS188149266 Health Risk Conflicting classifications of pathogenicity
RS199729402 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS201246173 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS201251711 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa
RS201445121 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS370051807 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS370813334 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS372097432 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa
RS376512605 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS376553923 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Inborn genetic diseases, Junctional epidermolysis bullosa
RS532836837 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS553672320 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS570770124 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS751052489 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS752690286 Health Risk Conflicting classifications of pathogenicity Inborn genetic diseases, Inborn genetic diseases
RS756432879 Health Risk Conflicting classifications of pathogenicity Inborn genetic diseases, Thyroid cancer, nonmedullary
RS771520608 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS773229937 Health Risk Conflicting classifications of pathogenicity Inborn genetic diseases, Inborn genetic diseases
RS774558289 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS78056473 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS886045625 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa
RS886045629 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS944567230 Health Risk Conflicting classifications of pathogenicity Junctional epidermolysis bullosa, Junctional epidermolysis bullosa
RS1043996591 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa, junctional 3B
RS1057516218 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516383 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516410 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516444 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516487 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516569 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516727 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
RS1057516935 Health Risk Likely pathogenic Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz
1 2 3 4 5 Next »
Sign Up to Analyze Your DNA Log In